Search - tctmd.com

Displaying 1 - 20 of 46

Sort: Relevancy | Date

News Daily News

Final CMS Decision Memo for Watchman Dumps Controversial Warfarin Contraindication

Shelley Wood

February 08, 2016

News Industry News

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

November 19, 2015

News Daily News

急性心肌梗死很少是由冠状动脉栓塞引起的，往往与房颤有联系

L.A. McKeown

July 08, 2015

News Daily News

Substantial Minority of Low-Risk A-fib Patients Still Given Anticoagulants

Salynn Boyles

April 28, 2015

News Industry News

Boston Scientific Announces First U.S. Commercial Procedures With The WATCHMAN™ Left Atrial Appendage Closure Device

March 24, 2015

News Daily News

先前——但不是新发作——房颤可预测TAVR后的长期结果更差

October 17, 2014

News Daily News

得到的FDA专家组支持率低，Watchman可能为时不多了

L.A. McKeown

October 16, 2014

News Daily News

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

L.A. McKeown

October 16, 2014

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Daily News

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

July 03, 2014

News Daily News

年度回顾：医生成为2013年最重要介入新闻主角

Yael L. Maxwell

January 27, 2014

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2013

Yael L. Maxwell

January 27, 2014

News Industry News

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

October 28, 2013

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

News Daily News

控制良好的华法林不会降低三联疗法出血风险

August 30, 2013

News Daily News

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

August 30, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

News Daily News

Apixaban Reduce el Índice de Hospitalizaciones compardo con la Aspirina en Pacientes con Fibrilación Auricular

Jason Kahn

August 05, 2013

News Daily News

Apixaban Lowers Hospitalization Rate vs. Aspirin in A-fib Patients

Jason Kahn

August 05, 2013

News Daily News

心房纤维颤动患者封堵装置血栓形成风险因素已被确认

Yael L. Maxwell

June 28, 2013

Advertisement

Final CMS Decision Memo for Watchman Dumps Controversial Warfarin Contraindication

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

急性心肌梗死很少是由冠状动脉栓塞引起的，往往与房颤有联系

Substantial Minority of Low-Risk A-fib Patients Still Given Anticoagulants

Boston Scientific Announces First U.S. Commercial Procedures With The WATCHMAN™ Left Atrial Appendage Closure Device

先前——但不是新发作——房颤可预测TAVR后的长期结果更差

得到的FDA专家组支持率低，Watchman可能为时不多了

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

年度回顾：医生成为2013年最重要介入新闻主角

Year in Review: Physicians Highlight the Most Important Interventional News of 2013

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

控制良好的华法林不会降低三联疗法出血风险

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

Apixaban Reduce el Índice de Hospitalizaciones compardo con la Aspirina en Pacientes con Fibrilación Auricular

Apixaban Lowers Hospitalization Rate vs. Aspirin in A-fib Patients

心房纤维颤动患者封堵装置血栓形成风险因素已被确认

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content